FDA approval of Eli Lilly's Alzheimer's drug cements our decision not to profit
Each weekday, the CNBC Investment Club with Jim Cramer publishes The Home Stretch, a handy evening update, just in time…
Eli Lilly and company
FDA approves Eli Lilly's donanemab drug for Alzheimer's
A sign with the company logo sits outside the Eli Lilly and Company headquarters campus on March 17, 2024 in…
Eli Lilly and drug makers show data on weight loss drugs
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…
Novo Nordisk to increase Wegovy and Ozempic production with new facility in North Carolina
New Novo Nordisk manufacturing facility in Clayton, North Carolina. Courtesy: Novo Nordisk Nordisk on Monday said it will spend $4.1…
Eli Lilly expects FDA to apply for Zepbound for sleep apnea in the short term
Eli Lilly On Friday it said it applied for U.S. approval of its weight-loss drug Zepbound for the treatment of…
More US employers cover GLP-1 for weight loss
Do you think a friend or colleague should receive this newsletter? Share this link with them to register. Wegovy injectable…
Eli Lilly, CFO Anat Ashkenazi on managing growing demand for LPG-1
A pharmacist holds boxes of Eli Lilly & Co. Mounjaro brand tirzepatide arranged at a pharmacy in Provo, Utah, U.S.,…
FDA advisors recommend donanemab, Eli Lilly's Alzheimer's drug
Eli Lilly headquarters in Indianapolis, Indiana, U.S., on Wednesday, May 3, 2023. Shares of Eli Lilly & Co. rose in…
AstraZeneca and drugmakers release promising cancer data
Attendees walk through the lobby of the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg…
Half of Workers May Have Difficulty Obtaining Obesity Drug Insurance Coverage
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…